
Raffaele Califano/YouTube
Aug 17, 2025, 14:09
Raffaele Califano: Recruiting Patients for Olomorasib Trial in Advanced NSCLC
Raffaele Califano, Professor of Medical Oncology at the University of Manchester, posted on LinkedIn:
“The Lung Team at the Christie is currently recruiting patients in a study using olomorasib in combination with pembrolizumab with or without chemotherapy for first-line treatment of patients with advanced NSCLC (non-small cell lung cancer) harbouring a KRAS G12C mutation please contact [email protected] for more information.”
More posts featuring Raffaele Califano on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 17, 2025, 14:09
Aug 17, 2025, 14:07
Aug 17, 2025, 14:05
Aug 17, 2025, 14:00
Aug 17, 2025, 13:57
Aug 17, 2025, 13:49
Aug 17, 2025, 13:43
Aug 17, 2025, 13:40
Aug 17, 2025, 13:26